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Abstract
Diabetes mellitus currently affects 8.3% of the world’s population, roughly 387
million people as of 2014, with numbers rising steadily. Diabetes is a major risk factor for
vascular pathology, affecting the vascular wall at the cellular and extracellular level. The
field of tissue engineering has proven to have great potential in treating cardiovascular
disease and kidney failure. In order to develop tissue-engineered replacements resistant to
the alterations induced by a diabetic environment, the modifications of the native tissues
are important to be elucidated.
Cardiovascular remodeling is due to elevated levels of fatty deposits along the
vessel wall, hyperglycemia and chronic inflammation. The major vascular matrix
components, such as collagen and elastin, interact irreversibly with the elevated levels of
blood glucose and lipids via oxidation and crosslinking processes resulting in the
formation of advanced glycation end products and vascular stiffening. Adventitial
fibroblasts, the “first-responder” to vascular injury, are involved in normal maintenance
of blood vessels, contributing to repair and remodeling. Adventitial fibroblasts play an
active role in the arterial response to injury, cytokines and stretch, which stimulate their
activation and differentiation into myofibroblasts.
Diabetes is also the most common cause of chronic renal disorders and end stage
renal disease. Diabetes results in a wide range of alterations in renal tissue such as
glomerular sclerotic lesions, hypertrophy of glomeruli, tubulointerstitial fibrosis,
increased expression of myofibroblasts and inflammation that contribute to kidney
ii

dysfunction and diabetic nephropathy. The aim of this study was to show the histological
changes of renal tissue associated with diabetes with an emphasis on remodeling of the
renal vasculature.
Kidney samples were explanted at a time point 3 months from diabetic and nondiabetic rats and were histologically analyzed for indications of pathological remodeling.
The sample cross sections were stained and analyzed for early signs of diabetic
nephropathy including glomerulus deterioration, vessel wall remodeling, and vascular
cell dyfunction. This was done using hematoxylin & eosin, Masson’s trichrome, periodic
acid schiff and various immunostainings for α-SMA, CD146, CD68, von Willebrand
factor and collagen type IV. Dense perivascular collagen deposition could be seen under
diabetic conditions. Increased macrophage infiltration was observed in diabetics as well
as increased pericyte and endothelial cell expression suggesting upregulation of
angiogenesis and increased remodeling and repair within the kidney. Myofibroblast
activity, the main contributing cell to organ fibrosis, was upregulated in diabetics
showing early signs of kidney fibrosis – a common outcome in diabetic nephropathy.
In conclusion, determining the modifications induced by diabetes at a vascular
cell and extracellular level could lead to finding optimal treatments for renal artery
disease and improved kidney tissue engineering approaches.
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1 Introduction
The kidneys are paired organs that are primarily involved in the urinary system,
but also associated with several other bodily systems, including the cardiovascular and
endocrine system. They play a critical role in a variety of physiological functions
including the excretion of waste products, elimination of foreign substances, regulation of
blood pressure and total body water, control of acid-base balance and regulation of bodily
salts concentration. In order to perform these functions, the kidneys are highly
vascularized and receive a significant amount of blood flow 1. Because of this high
amount of blood flowing in and out of the kidney, the cardiovascular system and the
kidneys are acutely dependent on each other, and kidney dysfunction can exacerbate and
accelerate cardiovascular disease 2.
The vascular system is a dense network of blood vessels carrying nutrients, gases
and waste products to their respective destinations. While they range in size, mechanical
properties and functionality, the general composition of blood vessels remains the same
throughout the vasculature. Vessels are composed of cellular constituents, such as
endothelial cells, fibroblasts and smooth muscle cells (SMCs), and extracellular matrix
proteins, primarily consisting of collagen and elastin. These basic constituents are
typically arranged in three concentric layers: intima, media and adventitia (Fig. 1, 2),
each serving a distinct mechanical and biological function 3. It is essential to understand
the mechanics and functionality of the vascular wall to attempt to closely mimic these
characteristics of native vessels when conceptualizing a replacement vascular graft, as an
ideal substitute should mimic the native vessels as closely as possible.
1

Figure 1: Diagram of the basic structure of an artery, including the intima with an
endothelial layer and basement membrane, the media consisting of a heavy population of
SMCs is between the internal and external elastic lamina, and the adventitia is shown
with a concentration of collagen with scattered cells. (From Kumar, et al. 8th ed., 2010)

2

Figure 2: Micrograph of a cross section of a porcine renal artery. The three layers of the
vascular wall are clearly defined. The intima is simply the epithelial layer lining the
lumen. The media is the mostly red section with smooth muscle staining red. The thick
collagen (blue) deposits can be seen in the adventitia with spare amounts in the media.
(Masson’s Trichrome (MT) & Verhoeff Van Gieson (VVG) Staining, 100X)

1.1 Blood Vessel Structure
1.1.1 Intima
The intima, the innermost layer of the blood vessel, is a thin layer of cells that
coats the internal lumen of the vessel along with a surrounding basement membrane. The
intima consists of a layer of simple squamous endothelial cells, which line the entire
luminal surface of every vessel in the vascular system with a limited amount of elastic
3

fibers restraining the cells to the vessel wall 3. Endothelial cells are multifunctional cells
mediating hemostasis, neutrophil recruitment and hormone trafficking but their primary
function is controlling the flow of materials and white blood cells into and out of the
bloodstream 4,5. These cells regulate the flow of materials based upon local environments
and adjust their arrangement and concentration to adapt to local needs. When a
population of cells is becoming hypoxic, they increase their production of the
transcription factor hypoxia-inducible factor 1, which stimulates the production of
vascular endothelial growth factor (VEGF). VEGF stimulates endothelial cells to
proliferate and invade hypoxic tissue allowing angiogenesis to occur and subsequently
resupply oxygen to the tissue 5. Angiogenesis is continuously occurring to support
recurrent cycles of remodeling and in needs of repair where tissue damage is present

6,5

.

Despite a low turnover rate and a long lifetime, endothelial cells have the ability to
proliferate and migrate in the event of vascular injury where they serve a critical role in
vascular repair 5.
Pericytes are a heterogeneous group of extensively branched cells attached to the
abluminal side of microvessels throughout the vasculature that are crucial for vascular
homeostasis. These cells are embedded in the intimal basement membrane and
interdigitate between the luminal endothelial cells 7. Pericytes are multifunctional cells
positioned within capillaries and postcapillary venules that contribute in physiological
processes including vessel stabilization, regulation of vascular tone and blood flow,
maintenance of local tissue homeostasis, synthesis of extracellular matrix (ECM),
progenitor cell functions and participation in repair and inflammation
4

7,8

. These cells are

considered heterogeneous due to their variations in functionality, morphology, origin and
location within the body 8.

5

Figure 3: A magnified view of the blood vessel layer. (A) The intima is separated from
the media by a thin layer of elastin (black). The smooth muscle (red) is the main
component of the media with sparse collections of collagen (blue) scattered throughout.
(B) Shows the transition from the media to the adventitia with the external elastic
membrane separating the two layers. The black dots scattered throughout the adventitia
are adventitial fibroblasts. (MT-VVG, 200X)

1.1.2 Media
The media is the middle layer of the blood vessel wall and typically the thickest
layer in arteries. It consists of concentric sheets of smooth muscle tissue, composed
primarily of SMCs supported by loose connective tissue (Fig. 3) 6. The principal function
of vascular SMCs is contractile movement as they respond to local conditions and
sympathetic or endocrine stimulation and adjust the luminal diameter to control local
blood flow 9. These cells express isoforms of contractile proteins, specifically actin, that
6

allow the contractile action to occur. The most abundant of these isoforms is α-smooth
muscle actin (α-SMA). In arteries, the media is separated from the outer most layer, the
adventitia, by the external elastic membrane 6.

Figure 4: Diagram of the shape SMCs take in their relaxed state and in contracted state
with actin and myosin action. (From Martini, et al. 9th edition, 2012)

7

1.1.3 Adventitia
The adventitia is a collagenous sheath with scattered fibroblasts that encompasses
the vascular wall providing strength and stability by anchoring the blood vessel to
surrounding tissue. Adventitial fibroblasts are the main cell type within this layer and
become suspended within the ECM they have deposited. Additionally, the media and
adventitia incorporate a network of small arterioles called the vasa vasorum that supplies
blood to the cells on the blood vessel 6.

1.2 Arterial Blood Flow
Each of these various components and layers serve specific functions within the
blood vessel, and the composition of a blood vessel varies based on its distance away
from the heart. These structural variations are mainly confined to the media and the
extracellular matrix while the intima remains consistent across all blood vessels 3.
Arteries are divided into three categories: elastic arteries, muscular arteries and arterioles.
Elastic arteries, also known as conducting arteries, are large arteries carrying a high
volume of blood away from the heart such as the aorta and pulmonary arteries 3. With its
high content of elastin and few SMCs, the walls of elastic arteries are extremely resilient
and can withstand the pulsatile flow and pressure fluctuations exerted during the cardiac
cycle 6. During ventricular systole, the aorta expands to manage the high pressure and
stroke volume then recoils during diastole to propel blood to the peripheral arteries 3.
8

Elastic arteries are large enough to sustain these hemodynamic forces with lumen
diameters up to 2.5 cm. Elastic arteries distribute blood to muscular arteries, which
supply the body’s skeletal muscles and internal organs 6. Muscular arteries, such as the
mesenteric arteries and renal artery, are principally characterized by their thick media
layer of SMCs. Smooth muscle contraction and relaxation allows the muscular arteries to
control regional blood pressure and blood flow by actively changing the lumen size 3.
Muscular arteries range in size from 4.0 mm to 0.5 mm in internal diameter while
arterioles are 30 μm or less. Arterioles have a poorly defined adventitia and the media
ranges from one or two layers of smooth muscles cells to as little as a scattered number of
cells not forming a full layer in the smallest arterioles 6. Arterioles transition into the
capillaries, consisting of only endothelial cells, where nutrient exchange occurs before
proceeding into the venous system. Pericytes are present within the basement membrane
of these microvessels that extend into the endothelium of the vessel and control local
blood flow through the capillaries and venules 8.

1.3 Blood Vessel Pathology
1.3.1 Cellular Responses to Pathological Conditions
While the cellular components of the blood vessels play an essential role in the
functionality of vascular wall, they are also critical in pathological processes of the
vasculature. Under pathophysiologic conditions, vascular cells respond to their
9

environment and pro-inflammatory signaling, which disrupts their normal functionality
and significantly increases the risk of cardiovascular diseases. Blood vessels respond to
hypertension, dyslipidemia, hyperglycemia, oxidative stress and chronic inflammation.
Vascular remodeling, called arteriogenesis, is induced in response to chronic changes in
blood glucose, pressure and flow 3. Atherosclerosis was once thought of as narrowing of
the arterial lumen through the buildup of fatty plaques; however, there is extensive
remodeling occurring within the vascular wall that makes the development of the disease
more complex

10

. Upon atherosclerotic lesion formation, the expression of endothelial

cell adhesion molecules and pro-inflammatory cytokines attract leukocytes, which results
in accumulation within the vessel wall and progression of lesion formation

11

. Vascular

cells become activated and adjust their normal functions and express newly acquired
phenotypes under pathophysiologic conditions by a variety of factors including
cytokines, elevated hemodynamic stresses and lipid content, advanced glycation end
products (AGEs) and reactive oxygen species (ROS).

10

Figure 5: Pathway of chronic inflammation and the impact of leukocyte activation on
cellular responses. The release of growth factors and cytokines recruit and stimulate cells
to alter their phenotype and contribute to tissue damage repair, which involves heavy
deposition of ECM, specifically collagen. (From Kumar, et al. 8th ed., 2010)

1.3.2 Endothelial Cell Dysfunction
Luminal endothelial cells are multifunctional and play a critical role in vessel wall
homeostasis and circulatory function. The endothelium maintains a non-thrombogenic
blood-tissue interface that prevents leukocyte adhesion and controls the passage of
materials into and out of the bloodstream. However, the tight connections of the
endothelial cells can loosen under pathological stimuli and allow additional materials and
leukocytes to pass into the vascular wall 3.

11

Figure 6: Diagram of activators and the activator-induced phenotype of endothelial cells.
(From Kumar, et al. 8th ed., 2010)

Endothelial cell activation can be induced by pro-inflammatory cytokines that
promote leukocyte recruitment and attachment to the vessel wall 12. Activated endothelial
cells express cell-surface adhesion molecules while circulating leukocytes express
integrins in response to an inflammatory stimulus (Fig. 6)

4,13

. As this activated state

develops, the cells enter a progressive state called endothelial dysfunction where they
display an altered phenotype. Endothelial dysfunction is defined as a diminished
production of endothelium-derived nitric oxide (NO) and contributes to cardiovascular
disease

12,4

. Dysfunctional endothelial cells promote developmental mechanisms for
12

atherosclerosis including increased adhesion to inflammatory cells and platelets, initiation
of thrombus formation and increased ROS. While the cells diminish production of
vasodilators, mainly NO, they also increase in contracting factors, such as endothelin-1,
affecting the vasoreactivity of the smooth muscle cells

12,3

. Part of the endothelial cells’

normal function is to balance these responses, and the underlying SMCs react to these
imbalanced factors 3.

Figure 7: Diagram of NO pathway related to endothelial function. Endothelial nitric
oxide synthase (eNOS) synthesizes NO within the endothelium and releases it into the
bloodstream and across the SMCs cellular membrane. NO induces vasodilation of the
SMCs and reduces leukocyte and platelet adhesion. (From Kumar, et al. 8th ed., 2010)

13

1.3.3 Smooth Muscle Cell Dysfunction
Just as the media plays a large role in vascular wall repair and remodeling, SMCs
play a central role in dysfunctional remodeling. SMCs have the capacity to proliferate
and migrate if stimulated by growth promoters such as platelet-derived growth factor
(PDGF), thrombin, endothelin-1, and fibroblast growth factor (FGF). Inhibitors include
NO and transforming growth factor-β (TGF-β), which are both diminished when vascular
injury occurs (Fig. 7). Vascular injury or endothelial dysfunction incites SMC migration,
growth and proliferation, and extracellular matrix synthesis that result in the formation of
an enlarged intima called a neointima (Fig. 8). The SMCs of the neointima display a
synthetic phenotype and are considered de-differentiated while losing the ability to
contract 3.

Figure 8: Schematic diagram of intimal thickening, showing smooth muscle migration to
the intima, proliferation within the intima and extracellular matrix deposition within the
neointima. (From Kumar, et al. 8th ed., 2010)
14

1.3.4 Adventitial Fibroblast Dysfunction
In the past, the adventitia was considered nothing more than a simple connective
tissue sheath surrounding the blood vessels without a specialized function other than
support

14

. Most of the research regarding the pathogenesis of atherosclerosis and other

vascular diseases has been focused around intima and media dysfunction and the cellular
mechanisms associated with the development of atherosclerotic lesions. In 1962,
Schwartz and Mitchell showed that there was a positive correlation between the
population of infiltrating cells in the adventitia and the advancement of the
atherosclerotic plaque

15

. However, little attention was paid to this study or others like

this and efforts continued to focus on intima and luminal cell infiltration. There is now a
growing belief that the adventitia plays a heavy role in regulating the remodeling of the
vascular wall. Under vascular pathophysiological conditions, adventitial reactions are
common, involving inflammation and increased collagen deposition within the adventitia
and extending into the vascular wall and surrounding tissues 14. As previously mentioned,
inflammatory cells migrate into the vascular wall through luminal endothelial cells;
15

however, cells can infiltrate the adventitia through the vasa vasorum

. Adhesion

molecules such as P-selectin and vascular cell adhesion molecule 1 (VCAM-1) are
upregulated within the vasa vasorum contributing to the accumulation of inflammatory
cells within the adventitia making the adventitia a primary site for inflammation

16

.

Adventitial fibroblasts, the “first-responder” to vascular injury, are involved in normal
maintenance of blood vessels, contributing to repair and remodeling

17

. After tissue

injury, adventitial fibroblasts are activated by cytokines released by inflammatory and
15

resident cells, migrate to the media and differentiate into myofibroblasts to synthesize
extracellular matrix 18.

1.4 Renal Artery and Vasculature
1.4.1 Renal Artery and Vasculature Structure
The kidneys constitute less than 0.5% of total body weight but receive 20% of the
cardiac output making it an extremely prominent organ, particularly within the
cardiovascular system 19. The renal artery is an essential muscular artery supplying blood
to the kidneys for blood filtration. The renal artery enters the kidney through the hilum, a
prominent medial indentation that is the point of entry/exit for the kidney

20,6

. The renal

artery progressively branches into the interlobar, arcuate and interlobular arteries then to
afferent arterioles prior to the glomerulus (Fig. 9) 20.

16

Figure 9: Diagram of the renal vasculature network. The renal artery enters the kidney
and progressively branches into the segmental, interlobar, arcuate and interlobular
arteries. From the arcuate artery, the blood flows into the afferent areriole and into the
glomerulus for blood filtration. Then, it enters the efferent arteriole and into the
peritubular capillaries where it transitions into the venous system. (From Chade, 2013)
17

The glomerulus consists of a network of capillaries located in the renal corpuscle,
which is the primary site of blood filtration. The renal corpuscle consists of the
glomerulus and different supporting epithelial cells of the glomerular capsule also called
Bowman’s capsule. The capsule is lined with a simple squamous capsular epithelium,
which is continuous with the visceral epithelium that surrounds the glomerular capillaries
where the capillaries are joined with the afferent and efferent arterioles at the vascular
pole of the renal corpuscle 6. The visceral epithelium consists of large cells called
podocytes wrapping around the capillaries with projection processes called pedicels. The
pedicels interdigitate to create a fenestrated capillary network with narrow slits that
allows for a high diffusion rate within the renal corpuscle. Podocytes are recognizable by
their large and irregular nuclei (Fig. 10) 1. While podocytes play a central role in
filtration, the mesangial cells act as pericytes and control the capillary blood flow 6. The
mesangial cells are embedded within the mesangial or stalk region of the capillary
network and contain actin-like filaments that enable them to contract and regulate blood
flow 1,6.

18

Figure 10: (a) Diagram of the renal corpuscle displaying podocytes interdigitation. (b)
Micrograph of renal corpuscle and surrounding tubules and structures. (From OpenStax
College, 2013)

The kidney is unique in that it has a double capillary bed beginning in the
capillaries of the glomerulus then joining in the efferent arterioles before entering the
peritubular capillaries surrounding the renal tubules. After the peritubular capillaries, the
blood vessels transition into the venous system and progressively into the renal vein,
which exits the kidney through the hilum (Fig. 9) 20.

1.4.2 Renal Blood Filtration
The renal corpuscle acts as a blood filter in which a pressure gradient allows
water and ions to exit the capillary and enter the capsular space while retaining larger
materials like red blood cells and plasma proteins 1. This diffused fluid is called filtrate
and enters the renal tubule; a series of tubules that serve as sites for more secretion of
waste products and reabsorption of nutrients and water in the filtrate prior to the
19

formation of urine. Together, the renal corpuscle and renal tubule form the functional unit
of the kidney called the nephron 6. The renal tubule is composed of several regions of
diversified morphology with two convoluted tubules, beginning with the proximal and
ending with the distal, separated by a tubular loop called the nephron loop 1. The entrance
to the proximal convoluted tubule is directly opposite of the afferent and efferent
arterioles at the urinary pole of the renal corpuscle and is continuous with the Bowman’s
Space. Each section of the renal tubule is a site of diffusion for water, ions (mainly Na+
and K+), toxins and organic nutrients with the peritubular capillaries around the nephron
6

. Nephrons’ renal corpuscles are mostly located in the superficial cortex of the kidney

with the nephron loop dropping into the medulla.

1.4.3 The Renin-Angiotensin-Aldosterone System
The kidney also plays a major role in cardiovascular regulation with its
involvement in the renin-angiotensin-aldosterone system (RAAS). The RAAS is
responsible for increasing sodium and fluid reabsorption when the body is deprived of
sodium or water and is one of the main regulators of blood pressure 21,22. Juxtaglomerular
cells of the kidney release the enzyme renin in response to a decrease in renal blood
pressure, which begins an enzyme cascade in the bloodstream 6. Renin converts
angiotensinogen to angiotensin I, which is then cleaved by angiotensin-converting
enzyme (ACE) to create angiotensin II (Fig. 11) 21. Angiotensin II stimulates a number of
effects including stimulating the production of aldosterone and antidiuretic hormone
20

causing increased sodium and water reabsorption in the kidneys, stimulating thirst to
increase fluid intake and stimulating cardiac output and systemic vasoconstriction 6.

Figure 11: Pathway of the RAAS and its effect on physiology and pathology.
Angiotensin II has a direct effect on the vasculature inducing vasoconstriction. Indirectly,
21

angiotensin II induces increased sodium and fluid reabsorption in the kidneys through the
release of aldosterone. (From, et al., 2011)

In pathology, the RAAS is continuously activated under conditions such as
hypertension, renal artery stenosis and diabetes, which can further disease progression 21.
Systemic and glomerular hypertension contributes to the onset and progression of
diabetic kidney disease 23. Angiotensin II and aldosterone contribute to insulin resistance
by increasing oxidative stress and altering insulin-signaling

21

. Intervention within the

RAAS is a well-established therapeutic method in managing hypertension and diabetes to
mitigate organ damage

23

. ACE inhibitors and angiotensin receptor blockers have long

been used to slow cardiovascular and renal damage by controlling hypertension 23,21.

1.5 Diabetes Mellitus
1.5.1 Prevalence of Diabetes
Diabetes mellitus is a group of metabolic diseases where blood glucose levels are
elevated chronically due to ineffectual insulin production or response

24

. Diabetes is

reaching pandemic proportions with the number of people diagnosed with diabetes
doubling in the past 20 years 25. The growing prevalence of diabetes is especially stark in
developing countries as more people adopt western diets, and the governments of these
nations cannot keep pace with the number of patients and cost of care. An estimated 425
22

million people worldwide, or 8.8% of adults, are considered to be diabetic with that
number expected to grow to 629 million by 2045

24

. There are several pathogenic

processes that can contribute to the development of diabetes as detailed further below.

1.5.2 Pancreas Anatomy & Physiology
The pancreas is an essential organ that possesses an exocrine and endocrine
function. The exocrine function involves clusters of gland cells and their associated ducts
that secrete enzyme-rich fluid used for digestion. The exocrine-related cells called acinar
cells inhabit approximately 99% of the volume of the pancreas. Small clusters of cells
scattered throughout the pancreas called the islets of Langerhans, perform the pancreatic
endocrine functions. The pancreatic islets contain several types of hormone-producing
cells denoted by alpha (α), beta (β), delta (δ) and gamma (γ).
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Figure 12: Pancreas diagram. The acinar cells secrete digestive enzymes that are
incorporated with bile secreted from the gallbladder and transported into the small
intestine. The pancreatic islet is shown highlighting the alpha and beta cells and their
respective produced hormones of glucagon and insulin. (From OpenStax College, 2013)

γ-cells produce pancreatic polypeptide that influences the activity of the
gastrointestinal tract such as stimulating pancreatic enzyme release and inhibiting
intestinal motility. δ-cells contain somatostatin, which suppresses the release of insulin
and glucagon release. α-cells produce the metabolic hormone glucagon, which raises
blood glucose levels through glycogen breakdown and glucose synthesis in the liver.
Glucagon acts as the antagonist to the main anabolic hormone, insulin, which is produced
by β-cells (Fig. 12) 6.
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Figure 13: Regulatory pathway for management of blood glucose concentrations and the
action of glucagon and insulin. (From Martini 4th ed., 1998)

Insulin is responsible for promoting the transport of glucose from the bloodstream
into surrounding cells and the breakdown of the glucose into ATP
25

24

. When blood

glucose levels rise, insulin is released to increase cellular glucose uptake in target cells,
which include skeletal muscle and most organs. Cells that are considered insulindependent and possess receptors on their plasma membranes for insulin to bind, which
activate the cellular pathways for glucose transmembrane transport, glucose utilization,
glycogen synthesis and other cellular anabolic pathways (Fig. 14) 26.

Figure 14: Schematic showing effects of insulin binding on cellular pathways. (From De
Meyts P, 2016)

1.5.3 Pathology of Diabetes
Type 1 diabetes is caused by the destruction of the insulin-producing β-cells of
the pancreas due to an autoimmune reaction. Type 1 accounts for approximately 5% to
26

10% of all cases of diabetes. The most common type of diabetes is type 2 diabetes,
accounting for about 90% of diabetic patients. In Type 2 diabetes, there is a combination
of pathological defects 3. One defect is the decreased ability of insulin to act on peripheral
to stimulate glucose metabolism or inhibit glucose output. The other is the inability of the
pancreatic β-cells to produce the amount of insulin needed to properly compensate for
this insulin resistance 27.

Figure 15: Development of type 2 diabetes. Insulin resistance is associated with obesity
induced by adipokines, free fatty acids and chronic inflammation. Pancreatic β-cells are
27

stimulated to increase their synthesis and secretion of insulin to compensate. However,
this leads to β-cell failure and cell death resulting in to diabetes induction. (From Kumar,
et al. 8th ed., 2010)

With a deficient supply of insulin or ineffective insulin, hyperglycemia is a
defining characteristic of the disease 28. While the epidemiology of type 2 diabetes is well
understood, the management of the disease still poses a major challenge to clinicians and
patients

25

. If not properly managed, the chronic hyperglycemia of diabetes can cause

other conditions to develop including long-term organ dysfunction, damage and failure as
well as pathological cardiovascular remodeling 28.

1.5.4 Diabetes Connection to Vascular Disease
Diabetes is a major risk factor for vascular pathology, increasing the likelihood
for cardiovascular disease by 2-4 fold due to accelerating atherosclerotic plaques and
vascular stiffening, the hallmark of diabetes

29,30

. Diabetes, which affects the vascular

wall at the cellular and extracellular level, exacerbates and accelerates the development
of atherosclerosis. At the cellular level, the endothelium is injured under insulinresistance conditions as cells decrease their secretion of NO and increase their production
of endothelin-1 and ROS leading to endoplasmic reticulum stress and apoptosis;
processes that accelerate the early stages in atherosclerosis. In the media, hyperglycemia
stimulates the inflammatory synthetic phenototype of SMCs and heightens their
migration and proliferation

11,31

. Fibroblasts of the adventitia are affected by diabetes as
28

they are also stimulated to proliferate and migrate to the media and intima contributing to
medial SMC hypertrophy, neointimal growth, plaque thickening and fibrous cap
formation

32,14

. At the extracellular level, the major vascular matrix components interact

with the elevated levels of blood glucose, lipids and AGEs via oxidation and crosslinking
processes. AGEs are formed when a protein or lipid interacts with glucose through a nonenzymatic nucleophilic addition reaction between a free amino group and the reducing
sugar carbonyl group forming reversible early glycation products and Schiff bases before
transitioning to Amadori products 29,30.

Figure 16: Biochemical pathways of oxidation and cross-linking processes due to fatty
acids and glucose. (Image courtesy of Dhulekar et al., 2018)
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The rearrangement of the Schiff base into the Amadori product is called the
Maillard reaction and results in an irreversible crosslink between vascular wall proteins,
collagen and elastin, leading to vascular stiffening

34

. By the induction of crosslinking,

AGEs trap lipoproteins in the vascular wall accelerating atherosclerotic plaque formation
35

. The process of AGE formation is dependent on the amount of glucose in the

bloodstream and is accelerated in diabetes due to the hyperglycemic environment

34

.

AGEs have a receptor on endothelial cells termed RAGE, which is active in normal and
pathologic states. AGEs are found in plasma but accumulate in the vessel wall in diabetes
with their abundance and their interaction with RAGE. This interaction with the
endothelium induces the expression of VCAM-1, which binds circulating leukocytes to
vessel wall

29

. This leads to chronic inflammation, which is the common link between

diabetes and atherosclerosis. The mechanisms for the development of atherosclerosis are
not fully understood, but it is thought of as a response-to-injury model.

30

Figure 17: American Heart Association classification of evolution and progression of
human atherosclerotic lesions. The characteristic types of the lesion are enumerated on
the left of the flow diagram. From I to IV, the lesion progression consists mainly of lipid
deposition. The loop between IV and VI is a repetitive process illustrating how lesions
increase in thickness. (From Stary et al., 1995)

It is a chronic inflammatory and healing response to an endothelial injury that
evolves through the interactions of lipid deposits, leukocytes and normal cellular
components of the vascular wall. The genesis of atherosclerosis begins with the initiation
of a chronic endothelial injury on the vessel wall that includes hypertension,
dyslipidemia, hyperglycemia or other hemodynamic factors that activate the endothelial
31

cells, which initiates the inflammatory cell recruitment cascade 3. Once endothelial
activation occurs, chronic inflammation is promoted by recruiting platelets and
leukocytes, mainly circulating monocytes and lymphocytes, to attach to and migrate
through the endothelium 30. The adhered monocytes migrate to the intima where they are
differentiated into macrophages. With chronic dyslipidemia, lipoproteins accumulate in
the intima and become oxidized by oxygen free radicals generated by macrophages and
endothelial cells. These oxidized lipoproteins are ingested by macrophages and become
laden with the accumulation of lipids. The lipid-filled macrophages are called foam cells
and are rendered useless while attributing to the accumulation within the atherosclerotic
lesion. Growth factors and cytokines released by activated platelets, endothelial cell and
macrophages promote SMC migration and proliferation in the intima and ECM
deposition 3. The fatty streak lesion progresses into a complex, occlusive lesion with
layers of futile leukocytes and SMCs, lipids and necrotic debris surrounded by ECM
proteins called a fibrous plaque (Fig. 18) 36.
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Figure 18: Diagram showing the progression of an atherosclerotic lesion. Beginning with
the induction of a chronic endothelial injury (1), endothelial dysfunction is induced
33

leading to increased permeability, platelet adhesion and leukocyte adhesion and
migration (2). Accumulation of differentiated macrophages and migrated SMCs from
media within the intima occurs forming a neointima (3). Lipids are engulfed by
macrophages forming foam cells with lipids accumulating in the intima (4). A fibrous cap
is formed by extracellular matrix-depositing SMCs growing into the luminal space
severely inhibiting blood flow (5). (From Kumar, et al., 2005)

1.5.5 Diabetes and Renal Disorders
Diabetes is also the most common cause of chronic renal disorders including
kidney fibrosis, diabetic nephropathy, chronic kidney disease and end stage renal disease.
Approximately a third of type 1 diabetics and a half of all type 2 diabetics develop
chronic kidney disease

37

. Diabetes affects kidney function in a series of stages as

diabetic nephropathy develops 38. The onset of diabetes results in an elevated glomerular
filtration rate and the size of the kidneys increases by approximately 20%

39,38

. After the

hyperfiltration stage, the glomerular filtration rate begins to regress back to normal levels
while microalbuminuria, an increase in the amount of the plasma protein albumin in the
urine, develops suggesting the onset of nephropathy. From there, the glomerular filtration
rate falls to levels that are synonymous with chronic kidney failure and proteinuria
develops. Glomerular filtration rate and proteinuria are the best indicators for the
progression of the disease, and once chronic kidney failure develops, the damage and
reduced function are irreversible 38.

34

1.5.6 Role of Pericytes in Renal Pathology
Pericytes are present in all vascularized tissue including in the kidney and play a
significant role in the functionality of the kidney. Subsets of renal pericytes with distinct
functionalities have been identified including renin-secretion of the pericytes of the
juxtaglomerular arterioles that control blood flow to the glomeruli, mesangial cells,
which support the glomerular structure, and glioma-associated oncogene-expressing
pericytes, which contribute to fibrosis 19.

Figure 19: The juxtaglomerular complex and glomerulus. (From Shaw, et al., 2018)
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The upregulation of signaling pathways such as TGF- β and PDGF induces the
proliferation and differentiation of pericytes into myofibroblasts 40. It has been suggested
that renal perictyes possess multiple tissue-regenerative properties that are phenotypic of
mesenchymal stem cells, and pericytes have been shown to be precursors to these
multipotent cells 19. Pericytes show this regenerative potential in injured skeletal muscle,
ischemic heart tissue, gone and adipose tissue and with their prevalence in all
vascularized tissue, serve as local reservoirs of regenerative cells 41.

1.5.7 Myofibroblasts in Renal Pathology
Fibrosis is a normal part of wound healing and repair to maintain the original
tissue architecture and function. An infiltrative response from pro-inflammatory cells
such as monocytes/macrophages, lymphocytes and mast cells into injured tissue is
required to stimulate tissue repair through the release of fibrogenic cytokines

23

.

Myofibroblasts are reactive cells that are stimulated under pathological conditions to
deposit ECM. Because fibrosis is the final common pathway of several renal diseases,
myofibroblasts have increasingly become a cell of interest in renal pathology 7.
Myofibroblasts are contractile and are identifiable by their expression of α-SMA, the
actin isoform characteristic of vascular SMCs 42. α-SMA forms bundles of myofilaments
called stress fibers that exert mechanical forces when the cell contracts causing matrix
reorganization 7. Myofibroblasts are considered the main collagen-producing cells
synthesizing interstitial ECM components such as collagen type 1 and III in wound
36

healing, cancer and organ fibrosis

43,44

. Myfibroblasts are commonly associated with

pathology as they are rarely found in normal tissue and are terminally differentiated from
multiple cell types

44

. The role and functionality of myofibroblasts is well understood;

however, their origin is a more unknown subject 43. Pericytes and perivascular adventitial
fibroblasts have been shown as the primary source for myofibroblast differentiation in
kidney fibrosis 45.

Figure 20: Fibroblast induction and differentiation into myofibroblasts. (From Meran, et
al., 2011)
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However, other studies have shown pericytes do not contribute to kidney fibrosis,
and that most myofibroblasts are derived from resident tissue fibroblasts, and to a lesser
degree, endothelial and epithelial cells. Bone marrow-derived cells can differentiate into
myofibroblasts under the influence of TGF-β. As seen with vascular SMCs dedifferentiating and gaining a fibroblast-like phenotype producing ECM, resident tissue
fibroblasts can proliferate and gain a contractile functionality

43

. Although their precise

origin is debated, the differentiation into myofibroblasts is considered one of the key
cellular events in the development of organ fibrosis 43,42.

1.5.8 Renal Morphological Changes Induced by Diabetes
A wide range of morphological changes in renal tissue can be attributed to diabetes
such as glomerular sclerotic lesions, hypertrophy of glomeruli, tubule-interstitial fibrosis,
tubular hypertrophy, increased expression of myofibroblasts and inflammation that
contribute to kidney dysfunction and diabetic nephropathy

46

. Glomerular basement

thickening is the first measurable morphological change caused by diabetes with tubular
basement membrane thickening quickly ensuing

47

. This is due to the increased rates of

synthesis for basement proteins such as laminin, collagen type IV and fibronectin due to
diabetes particularly during the beginning phases of the disease 48. Hypercellularity of the
glomerulus is a common characteristic of inflammatory responses associated with a
systemic disease like diabetes including an infiltration of leukocytes within the
glomerulus and the peritubular capillaries 3. In addition, mesangial cells tend to divide
38

and proliferate in certain kidney disease 1. In type 2 diabetes, mesangial expansion is a
major morphological change preceding loss of renal function

47

. The severity of the

morphological changes to the glomeruli are proportional to glomerular filtration rate,
diabetes duration and blood glucose regulation 38.

1.6 Tissue Engineering as a Solution to Diabetes-induced Remodeling
1.6.1 Challenges and Solutions

With the extensive pathological remodeling that occurs in diabetic vasculature and
kidneys, it is important to fully understand the cellular and extracellular mechanisms
behind the tissue remodeling. This is of particular importance in tissue engineering,
where the goal is to replace or repair the damaged tissue with a replacement that is
resistant to the pathophysiological conditions preventing further tissue deterioration

49

.

With blood vessel tissue-engineered replacements, a biodegradable or biocompatible
scaffold that mimics the wall properties of the native vessel is seeded with autologous
stem cells prior to implantation. Additionally, the graft can be conditioned prior to
implantation to condition the wall to the local environment and allow for remodeling and
graft maturation

29

. These tissue-engineered grafts present various challenges including

non-thrombogenicity, adequate burst pressure and compliance, inflammatory responses,
appropriate remodeling responses and vasoactivity 50. For diabetic patients, an additional
challenge is the aggressive oxidative environment generated by the hyperglycemia and
39

dyslipidemia characteristic of diabetes that induces inflammation, tissue degeneration and
impaired tissue remodeling 29.

Figure 21: Diagram of the process behind a tissue-engineered vascular graft. A porcine
blood vessel is harvested and decellularized to act as a scaffold. Stem cells are harvested
from the patient and cultured, propagated and seeded onto the scaffold. The graft can then
be conditioned chemically and mechanically for maturation in a bioreactor as needed
prior to implantation. (Image courtesy of Dhulekar et al., 2018)
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With the direct dependence the kidneys have on the vascular system, their
morbidities are commonly associated and are also a target for tissue engineering
therapies. Revascularization is a critical part of graft acceptance for replacement vessels
and kidneys of the replacement graft in order to support and sustain the graft components.
In blood vessels, complete tissue integration and vasa vasorum formation are essential for
graft acceptance

51

. The mechanisms behind the development of the renal

microvasculature are not fully understood but thought to arise from angiogenesis or
during kidney development

49

. Kidney decellularization offers a unique solution to this

problem by providing a biological scaffold to be recellularized with host cells to provide
functionality and no immune response from the host. This method preserves the structural
components of the kidney including the collagen, elastin, laminin and fibronectin of the
vasculature and basement membrane. Recellularization presents another challenge to
overcome for successful graft. This typically involves a constant infusion of cells in an in
vitro setting such as a bioreactor 52.
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Figure 22: General representation for the decellularization and recellularization process
for a functional kidney. (From Destefani, et al., 2017)

1.6.2 Need for Improved Therapies
With the degenerative effects on the vasculature and kidneys associated with
diabetes, solutions are needed to mitigate these risks and improve patient outcomes.
When a patient’s renal function declines to end stage renal disease levels, their treatment
options are essentially limited to dialysis and transplantation. While dialysis does
decrease mortality, it has significant limitations including morbidity, convenience and
cost. Allogenic transplantation is the optimal treatment with benefits in mortality and
cost-saving but is limited by the scarcity of available donated organs
42

53

. Renal

pathologies also accelerate the progression of cardiovascular disease. In patients with end
stage renal disease, cardiovascular mortality is 15 to 30 times higher than the ageadjusted cardiovascular mortality in the general population. The relationship between
renal function and cardiovascular mortality also applies to people with more moderate
degrees of impaired renal function 2.
While advances have been made in vascular graft technology resulting in declining
arterial disease-related mortality, this improvement has not been observed in diabetics 29.
Diabetic patients have been shown to have a higher incidence of restenosis with drugeluting stents and occlusions in coronary artery bypass grafting using a saphenous vein at
54,55

1-year

. With these challenges to synthetic grafts, the current “gold standard” of

vascular grafts are autologous vessels such as the internal thoracic artery and saphenous
vein

56

. However, about 1/3 of patients (approximately 140,000 each year) do not have

vessels suitable for grafting due to age or systemic vascular disease

29

. Synthetic grafts

are used an alternative to autologous grafts, but these promote more challenges to
properly mimic the mechanical and biological functions of a native vessel. Synthetic
vascular grafts with large and medium diameters have shown promise with long-term
patency rates; however, synthetic grafts are not suitable for smaller diameter vessels
(<6mm) as occlusion occurs far too quickly 57.
The field of tissue engineering has proven to have great potential in vascular graft
and organ regeneration. In order to develop tissue-engineered replacements resistant to
the alterations induced by a diabetic environment, it is essential for the modifications of
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the native tissue to be elucidated. The aim of this study is to histologically analyze the
morphological changes of renal tissue associated with diabetes with an emphasis on
remodeling of the vasculature and to use these findings to better utilize tissue engineering
to mitigate damaging morphological alterations due to diabetes.

2

Materials and Methods

2.1 Animal Model
The diabetic animal model was developed as described before

58

. Briefly, adult

male Sprague Dawley rats (n=40, weight 300–350 g) were rendered diabetic via a single
dose of sterile filtered 55 mg/kg streptozotocin (STZ) solution in 0.1 M citrate buffer (pH
5) by tail vein injection (day zero). Control rats (n=40) received an equal volume of
vehicle (sterile citrate buffer). Starting on day 3, levels of blood glucose in all diabetic
rats were determined 3–4 times per week, using AlphaTRAK (Gen II) test strips on the
AlphaTRAK Blood Glucose Monitoring System, designed specifically for animals.
Glycemia levels were also assayed weekly in the control, non-STZ treated rats. Diabetes
was established (>400 mg glucose/dL blood), and diabetic rats were given subcutaneous
injections of long-lasting insulin (2–4 U Isophane) every other day to maintain blood
glucose level in a desirable range (400–600 mg glucose/dL blood) and prevent development of ketonuria and weight loss. Control rats exhibited mean glycemic levels of 128+/44

12 mg glucose/dL blood. Glucose levels, individual weights, hydration status, and food
and water consumption were monitored closely to ensure adequate health parameters.
Animals were provided with food and water ad libitum and were cared for by the
attending university veterinarian and associated staff at the Godley-Snell Research Center
animal facility at Clemson University. The Animal Research Committee at Clemson
University approved the animal protocol (AUP 2011-002), and National Institute of
Health (NIH) guidelines for the care and use of laboratory animals (NIH publication #86–
23 Rev. 1996) were observed throughout the experiment. The experimental animals used
in this study were part of an abdominal-aortic graft trial as this study was a subsidiary
study of a vascular graft trial. The grafts used in the trial were decellularized porcine
arteries with half being treated with penta-galloyl glucose (PGG), an elastin stabilizing
agent, and half untreated. These grafts were implanted in non-diabetic and diabetic rats
with one rat being left as a control.
2.2 Tissue Collection
At 3 months, the animals were euthanized, and the kidney samples were
explanted. At the point of extraction, the kidneys were bilaterally sectioned along the
hilus using a scalpel. This was done to ensure proper tissue fixation due to the kidney’s
dense fibrous cortex makes it difficult for formalin to penetrate into the renal tissue. Each
sample was then washed with phosphate-buffered saline to remove all blood and placed
immediately in 10% neutral buffered-formalin upon explant. The samples were left in
formalin for 48 hours to allow for tissue fixation before proceeding to tissue processing.
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2.3 Sample Processing
The samples were properly processed using a graded alcohol procedure in the
tissue processor and paraffin-embedded. The embedded samples were sectioned at 6 μm
using a microtome. The sections were placed on a warm water bath before placing them
on a microscope slide. The microscope slides were left to dry on a slide warmer before
placing them in an oven at 56°C for 30 minutes to properly adhere the section to the
slide. The sample cross sections underwent various histological stains for analysis.
For each staining procedure, the samples were deparaffinized and rehydrated
through the following procedure: 3x5 min in xylene, 2x5 min in 100% ethanol, 2x4 min
in 95% ethanol, 3 min in 85% ethanol, 3 min in 70% ethanol, 3 min in 50% ethanol,
dipping in tap water until the alcohol sheet is gone and 3 min in DI water.

2.4 Hematoxylin & Eosin Stain
To observe glomerular remodeling, cellular interactions and tubular remodeling,
hematoxylin & eosin (H&E) staining was used. Sections were deparaffinized as described
above and were then stained in hematoxylin for 6.5 min then placed in running water to
wash away excess hematoxylin. This was followed by 6 dips in Clarifier then again
dipping in tap water until the alcohol sheet is gone. Then, the samples were immersed in
Bluing reagent for 1 min followed by tap water for 1 min. Then, placed in 10 dips of 95%
ethanol to dehydrate before staining with eosin for 45 seconds. The samples were then
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dehydrated again before cover slip mounting by the following procedure: 2x10 dips in
95% ethanol, 10 dips in 100% ethanol, 2x2 min in 100% ethanol, 5 min in xylene and 5
min in xylene.

2.5 Glomerular Basement Membrane Thickening Analysis
Periodic Acid Schiff (PAS) Stain was used to determine the extent of glomerular
basement membrane thickening. After deparaffinization, the slides were immersed in
Periodic Acid Solution for 10 min then rinsed in four changes of distilled water. The
slides were then immersed in Schiff’s Solution for 30 min before rinsing in hot running
tap water. Next, the slides were stained in Modified Mayer’s Hematoxylin for 3 min and
rinsed in running tap water for 3 min. The slides were then placed in Bluing Reagent for
30 sec before being rinsed in distilled water and dehydrated to xylene before coverslip
mounting.

2.6 Perivascular Fibrosis Analysis
Perivascular fibrosis of the renal vasculature was analyzed using Masson’s
Trichrome (MT) stain (Poly Scientific). The samples were deparaffinized and rehydrated
before placing in Bouin’s Fixative at 56°C for 1 hour. The samples were then cooled and
washed in running water until the yellow color disappeared from the samples. After, the
samples were stained in Weigert’s Iron Hematoxylin Working Solution for 10 min then
47

washed in running water for 10 min before rinsing with DI water. They were then stained
in Biebrich Scarlet Acid Fuchsin for 2 min and rinsed again in DI water. Next, they were
placed in Phosphotungstic Phosphomolybdic Acid for 15 min then Aniline Blue Solution
for 5 min. The samples were then rinsed with DI water and placed in Acetic Acid 1%
Aqueous for 5 min before proceeding to dehydrating and mounting.

2.7 Macrophage Localization
To determine the extent of inflammation within the kidney, macrophage
localization was performed through immunohistochemistry (IHC) using the anti-CD68
antibody (ab955 - Abcam). The CD68 antibody is a heat-mediated antibody; therefore,
the samples were placed in a pressure cooker at 320°C for 5 min with 160 mL of citrate
buffer in 1440 mL of DI water (pH 6.0). This was followed by 3 rinses and 3 washes for
5 min with DI water. Blocking was done through endogenous peroxidase with 0.3% H2O2
in 0.3% normal serum in Tris-buffered saline (TBS) for 10 min. The sections were rinsed
twice with 0.025% Triton for 5 min to permeabilize the cellular membranes and then
repeated the TBS rinse and wash cycle. The sections were incubated in normal serum for
20 min to block unspecific blocking sites. The sections were then blotted before applying
the primary antibody made in Tris-NaCl-blocking (TNB) buffer. For this CD68 antibody,
the antibody was diluted to 1:100 TNB buffer. Negative controls only received TNB
buffer. The samples were incubated overnight at 4°C with the primary antibody. The TBS
rinse and washing cycles were repeated before the secondary antibody was applied. The
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secondary antibody was made using 30 μL of normal blocking serum in 2 mL TBS and
10 μL of biotinylated anti-mouse IgG. The secondary antibody was applied for 1 hour at
room temperature and then rinsed and washed in TBS. Avidin/Biotinylated enzyme
Complex (R.T.U. Vectastain ABC Reagent – Vector Laboratories, Inc.) was applied for
30 min at room temperature and then rinsed and washed in TBS. The samples were then
developed for 3-5 min with a DAB substrate solution (DAB Peroxidase Substrate Kit –
Vector Laboratories, Inc.) consisting of 5 mL of DI water, 2 drops of Buffer Stock
Solution, 4 drops of DAB Stock Solution, 2 drops of H2O2 and mixed well. The time for
development was determined by checking the samples under a microscope for proper
exposure. The samples were rinsed and washed in TBS then placed in tap water for 5 min
before counterstaining in hematoxylin for 2 min. The samples were then dehydrated
following the procedure previously described and mounted.

2.8 Myofibroblast Localization
Myofibroblast localization was performed through IHC using the anti-α-SMA
antibody (ab5694 - Abcam) to determine the extent of kidney fibrosis progression.
Antigen retrieval was done through heat-mediation, the primary antibody was diluted at a
concentration of 1:200 TNB buffer and required a rabbit secondary antibody. Otherwise,
the procedure is the same as described above.
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2.9 Basement Membrane Thickening
Tubule-interstitial basement membrane thickening was analyzed using anticollagen type IV antibody (ab6586 – Abcam). Antigen retrieval was done through heatmediation, the primary antibody was diluted at a concentration of 1:500 TNB buffer and
required a rabbit secondary antibody.

2.10 Pericyte Localization
Pericyte localization was performed through IHC using the CD146 antibody
(ab75769 - Abcam) to determine if there was an upregulation of proliferation and
migration of pericytes. Antigen retrieval was done through heat-mediation, the primary
antibody was diluted at a concentration of 1:200 TNB buffer and required a rabbit
secondary antibody.

2.11 Endothelial Cell Localization
Endothelial cells were localized using an anti-von Willebrand Factor (vWF)
antibody (ab6994 - Abcam) to determine if repair and remodeling was occurring through
angiogenesis. This antibody requires antigen retrieval through 0.1% Proteinase K in TBS
applied to the sections for 40-60 seconds. The primary antibody was diluted at a
concentration of 1:250 TNB buffer and required a rabbit secondary antibody.
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2.12 Histological Quantification and Statistical Analysis
Micrographs of the stained kidney sections were taken to draw observable
conclusions and generate quantifiable data. Using an image processing software
(ImageJ), particle density was measured by setting the color hue to the appropriate range
for the color of interest. This range was kept constant for all images of each respective
staining while the saturation and brightness of the image was variable for each image to
diminish noise. The particle density measurement was generated as a percent area of the
image, and the mean percent area was calculated for the non-diabetic and diabetic groups
for each staining. A t-test was performed to determine statistical significance between
non-diabetics and diabetics for all quantified data sets.

3 Results
The animal weights were maintained within 25% of their starting weight for the
duration of the study. Diabetic rats blood glucose level were maintained at or above 400
mg/dl for the duration of the study (Fig. 23).
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Figure 23: Graph showing weights and blood glucose values of rats over time.

Figure 24: Explanted kidney samples.
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3.1 Glomeruli Alterations
The glomerulus consists of an anastomosing network of capillaries lined with
fenestrated endothelium. The glomerular basement membrane consists of collagen type
IV, laminin, polyanionic proteoglycans and several glycoproteins. Using histological
analysis of the kidney, we show that glomeruli are altered under diabetic conditions,
compared to non-diabetic environments. H&E staining shows that the glomeruli are
modified in diabetic animals (Fig. 25 and 26). Blood components are more infiltrated in
the diabetic kidney as the basement membrane are fenestrated endothelial cells are
injured. Furthermore, PAS staining, specific for proteoglycans and glycoproteins, shows
the thickening of the glomerular basement membrane in diabetes (Fig. 27). Both stains
highlight the hypercellularity characteristic of glomerular disease.

Figure 25: Non-diabetic glomeruli stained with H&E. These glomeruli exhibited no
observable alterations.
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Figure 26: Diabetic glomeruli stained with H&E. Diabetic glomeruli exhibited
hypercellularity of the mesangium (A,C), potential glomerular sclerotic lesions (D),
hyperfiltration (A,B), loss of the Bowman’s space (A,B,D) and possible collapse of the
capillary bed (B).
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Diabetic

Non-Diabetic

Figure 27: Micrographs of non-diabetic (left) and diabetic glomeruli (right) stained with
PAS. There is a heavier deposit of magenta in the diabetic glomeruli proving there is a
thickening of the glomerular basement membrane.

3.2 Perivascular Fibrosis Quantification
MT was used for perivascular fibrosis analysis. MT stains nuclei – black, collagen
– blue and cytoplasm and muscle fibers – red. Micrographs were taken of non-diabetic
and diabetic renal arterial blood vessels of ranging sizes. All blood vessels analyzed had
to be a true lateral cross-section of the vessel to avoid skewed measurements. ImageJ was
then used to measure the luminal diameter and vessel wall thickness and to analyze the
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particle density of blue (collagen) between the blood vessel and the renal tissue (Table 1).
A two-sample t-test was performed at α=0.05 to determine statistical significance
between the percent concentration of collagen of non-diabetic and diabetic blood vessels.
The average wall thickness and the concentration of perivascular collagen were both

Diabetic

Non-Diabetic

found to be statistically significant between the non-diabetic and diabetic population.

Figure 28: Perivascular fibrosis in non-diabetics (above) and diabetics (below). All
images shown above have been stained with Masson’s Trichrome. Non-diabetic samples
can be seen on the top row. Sparse collagen deposits can be seen around all non-diabetic
blood vessels. Diabetic samples can be seen on the bottom row. (A) and (B) have a
luminal diameter of <60 µm and a collagen percentage of 12.5% and 31.5%, respectively.
(C) and (D) have a luminal diameter of >60 µm and a collagen percentage of 16.5% and
29.7%, respectively. (E) and (F) have a luminal diameter of >100 µm and a collagen
percentage of 18.4% and 38.5%, respectively. A heavier concentration of collagen and
interstitial ingrowth of collagen can be seen in all diabetic samples.
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Table 1: Perivascular Fibrosis Quantification
Sample
Luminal
Avg. Luminal Avg. Wall
Type
Diameter
Diameter
Thickness
2
Range (Sample (Range) [µm ] (µm)
Size) [µm]

NonDiabetic

Diabetic

Avg. Area
of Interest
(µm2)

Avg. Area
of Collagen
(µm2)

<60 (n=11)

41.87 (19.556.4)

15.91

12987

2057

>60 (n=10)

93.76 (61.3129.6)

22.96

33477

5621

All (n=21)

66.58

19.26

22744

3754

<60 (n=12)

39.87 (23.758.2)

26.46

19278

5101

>60 (n=9)

104.34 (61.6135.8)

29.20

34573

8349

All (n=21)

64.43

27.63

25105

6338
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Avg. Wall Thickness (µm)

40
35
30

*

*

25

*

20

Non-Diabetic

15

Diabetic

10
5
0
<60 µm

>60 µm
Vessel Lumen Diameter

All

Concentration of Perivascular
Collagen (%)

35
30
25

*

*

*

20
Non-Diabetic

15

Diabetic

10
5
0
<60 µm
>60 µm
Vessel Lumen Diameter

All

Figure 29: Analysis of average wall thickness between non-diabetic (Blue) and diabetic
(Red) animals organized by luminal diameter (Top). Analysis of concentration of
collagen surrounding the blood vessels (Bottom). This was calculated by measuring the
amount of blue color and dividing it by the total area of interest (area within where the
fibrous capsule of the blood vessel meets the renal tissue).
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Table 2: p-values (α=0.05) for Average Wall Thickness and Perivascular Collagen
Concentration
Vessel Luminal Diameter Avg. Wall Thickness Collagen Concentration
<60 µm

1.13x10-5

7.50x10-6

>60 µm

0.031

0.036

All Vessels

1.70x10-5

8.46x10-7

3.3 Inflammation Assessment
As previously described, pro-inflammatory cell infiltration is a precursor to
chronic remodeling and fibrosis as they release growth factors and activators to
endothelial cells and fibroblasts to alter their phenotype. Therefore, if inflammatory cells
are present, chronic remodeling and fibrosis is likely to follow. To assess the degree of
inflammation within the kidney, IHC was performed with anti-CD68 antibody to localize
infiltrating macrophages. CD68 is a specific marker for macrophages. Images taken from
diabetic samples can be seen below (Fig. 30).
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Figure 30: Micrographs of diabetic kidneys stained with anti-CD68 antibody localizing
macrophages. This shows an increased infiltration of macrophages within the renal
vasculature.

3.4 Tubular Basement Membrane Thickening Assessment
In addition to the vasculature, the tubulointerstitium was analyzed for remodeling
and collagen deposition. The metabolic consequences of diabetes like hyperglycemia
induce tubular remodeling and increased collagen deposition. To determine the degree
tubular basement membrane thickening, IHC was performed using anti-collagen type IV
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antibody. Collagen type IV is the main protein in the glomerular basement membrane and
Bowman’s capsule and stains a light brown color.

Figure 31: Micrographs of non-diabetic kidneys stained for collagen type IV. No
deposits of collagen were seen within the tubulointerstitium space.
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Figure 32: Diabetic kidney sections stained for collagen type IV. Collagen deposits
(Brown) can be seen within the tubulointerstititum space in the cortex (A, C, D) and
medulla (B). Heavier deposits could also be seen within the glomerular basmement
membrane and Bowman’s capsule (A, C, D).

3.5 Myofibroblast Localization
Fibrosis is a normal part of wound healing and repair to maintain the original
tissue architecture and function as well as during pathological remodeling. To determine
the degree of kidney fibrosis, kidneys were stained for α-SMA, the main protein
expressed by contractile cells. Myofibroblasts are reactive cells that are stimulated by
cytokines and growth factors released by pro-inflammatory cells under pathological
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conditions to deposit ECM. Myofibroblasts utilize α-SMA and are the main collagen
depositors in organ fibrosis; therefore, myofibroblast activity is a good marker for kidney
fibrosis progression.

Figure 33: Non-diabetic kidney sections stained for α-SMA. No deposits of α-SMA were
seen in the tubulointerstitium space. Deposits were seen in blood vessels, which is a well
established outcome and was expected.

63

Figure 34: Diabetic kidney sections stained for α-SMA. Increased deposits could be
throughout the renal tissue (A). Deposits could be seen within the renal tubules showing
tubule degeneration with increased myofibroblast activity (C,D).

3.6 Pericyte Localization
Pericytes are particular cells of interest in vascular dysfunction, as they serve as a
support for the endothelial cells but also have mesenchymal stem cell properties. CD146
is a specific marker for pericytes. Using anti-CD146 antibody, we show the accumulation
of pericytes in diabetes as the number of capillaries is increased, leading to infiltration of
inflammatory cells and cells involved in fibrosis and pathological remodeling.
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Non-Diabetic

Diabetic

Figure 35: Non-diabetic kidney (A,C) and diabetic kidney sections (B,D) stained with
CD146 antibody. Increased pericyte expression could be seen in the tubulointerstitium
space in diabetics when compared to non-diabetics (A,B) and within the glomeruli (C,D).

3.7 Endothelial Cell Localization
vWF is a glycoprotein released by endothelial cells into circulation that is
involved in arterial thrombus formation. vWF is upregulated under risk factors such as
cardiovascular disease and diabetes or when endothelial cells dysfunction occurs 59. vWF
was used as a marker for endothelial cells.
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Non-Diabetic

Diabetic

Figure 36: Non-diabetic (A,C) and diabetic kidneys (B,D) stained for von Willebrand
Factor. Heavier positive staining deposits can be seen in diabetics in the
tubulointerstitium space (B) and within the glomeruli (D).

3.8 IHC Quantification
ImageJ was used to quantify the amount of positive binding in each of the five
IHC stains done. For collagen type IV, α –SMA, CD146 and vWF, the entire area of 5
non-diabetic kidney and 5 diabetic kidney sections were imaged at a magnification of
25X with each image quantified. This was done by particle analyzing the brown area and
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calculating the percent area of the brown in relation to the total area of each image. For
the kidney sections stained for macrophages with CD68, localized macrophages were
found in the sections and their percent area was quantified. This was done because the
particles cannot be analyzed at a low magnification and required a higher magnification
(100X). The average percent area for non-diabetics and diabetic are listed for each of the
five antibodies used as well as the standard deviations and p-values (Table 2). A twosample t-test was performed for each staining and each were found to be statistically
significant at α=0.01.
Table 3: Average Percent Areas for IHC
Sample Type
COLL IV
α -SMA

NonDiabetic

CD146

vWF

CD68

Avg. Percent

0.3783

0.3595

0.2975

0.4068

0.1369

Area (%)

(n=58)

(n=51)

(n=55)

(n=46)

(n=14)

Standard

0.2481

0.1442

0.1343

0.2312

0.0677

Avg. Percent

0.9456

0.8920

0.5631

0.5691

0.2591

Area (%)

(n=54)

(n=49)

(n=24)

(n=43)

(n=30)

Standard

0.3690

0.3605

0.1942

0.3096

0.1370

1.45x10-15

2.96x10-14

3.64x10-7

3.34x10-3

1.43x10-4

Deviation

Diabetic

Deviation
p-value (α=0.01)
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1.4
1.2

Percent Area (%)

1
*

*

0.8

Non-Diabetic

0.6

*

*

Diabetic

0.4
*

0.2
0
Coll IV

α-SMA

CD146

VWF

CD68

Antibody

Figure 37: Quantification of IHC staining results.

4 Discussion
Alterations to the structure of glomeruli were visible in the diabetic population.
While the sections stained hematoxylin & eosin were not quantified, they were used to
gain general observations about renal remodeling. Hematoxylin stains nucleic acids a
deep purple color while eosin unspecifically stains proteins pink
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Potential

hyperfiltration, mesangial cell proliferation, developing glomerular sclerotic lesions and
glomerular hypertrophy were observed (Fig. 26). To confirm these observations, PAS
was used, which stains basement membrane components such as polysaccharides and
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mucosubstances. A heavier deposit of these substances (magenta) could be seen in
mesangium confirming the thickened glomerular basement membrane (Fig. 27).
Dense perivascular collagen deposition was seen under diabetic conditions. This
was confirmed with quantification of the collagen deposits with non-diabetic and diabetic
blood vessels having an area collagen percentage of 16.1% and 25.4%, respectively. The
diabetic blood vessels analyzed had a smaller luminal diameter and thicker vessel wall
than the non-diabetic blood vessels displaying the narrowing of the lumen that is
characteristic of arteriosclerosis (Table 1, Fig. 29). The difference between non-diabetics
and diabetics for average arterial wall thickness and perivascular collagen concentration
were both found to be statistically significant at α=0.05 (Table 2).
The average percent area for all IHCs were found to be statistically significant at
α=0.05 between diabetics and non-diabetics (Fig. 37) (Table 3). Within the
tubulointerstitium, increased collagen deposition was confirmed. A type IV collagen
layer could be seen in the interstitial space between the renal tubules in diabetics while
none was observed in non-diabetics (Fig. 31, 32). Increased collagen type IV was also
ssen within the glomerular basement membrane and Bowman’s capsule (Fig. 32). An
increased presence of macrophages was seen in diabetics (Fig. 30). This is evidential by
the sample size for number of images between non-diabetics (n=14) and diabetics (n=30).
Infiltration of proinflammatory cells is a key event in not only inflammation but also lead
to repair as these cells release cytokines and growth factors that target cells that promote
remodeling including fibroblasts, endothelial cells and pericytes should also be increased.
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Therefore, if macrophages are upregulated, cells involved in wound healing and tissue
remodeling should also be more prevalent. Increased myofibroblast activity was observed
in diabetic kidneys with heavy deposits of α-SMA in the medulla and sparse deposits
within cortex and glomeruli (Fig. 34). This is evidential of advancing kidney fibrosis – a
common outcome in diabetic nephropathy. Pericytes and endothelial cells were in greater
abundance in diabetics in the medulla and within the glomeruli (Fig 35, 36). Both of
these vascular cell types are migratory and major contributors in angiogenesis. Their
increased presence shows that increased repair and remodeling is occurring in diabetic
kidneys.

5 Conclusion
The results of this study show that there is increased chronic repair and
pathological remodeling within diabetic kidneys in a short-term model. Given the
remodeling observed in the diabetic kidneys, the mechanism behind the response and
repair of the kidneys was important to be elucidated first before developing tissueengineered replacements. In conclusion, determining the modifications induced by
diabetes at a vascular cell and extracellular level could lead to finding optimal treatments
for renal artery disease and improved kidney tissue engineering approaches.
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6 Limitations and Future Work
Given the short timetable for the animal model in this study, a long-term animal
model is needed to observe and quantify the definitive effects on the kidneys due to a
diabetic environment. This animal model used was also an abdominal aorta graft model.
Further work would involve analyzing the remodeling of the renal artery in a diabetic
environment. This could be accomplished in an in vitro model utilizing a bioreactor to
mimic the hemodynamic forces and hyperglycemia of a diabetic environment.
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